Scarica l'app Stockscreener
74.14
3.10%
-2.37
Dopo l'orario di chiusura:
74.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Disc Medicine Inc Borsa (IRON) Ultime notizie
Disc Medicine Shares Polycythemia Vera Data, Outlines Late 2026 Trial Milestones - Benzinga
IRON Reiterated by Wedbush -- Price Target Maintained at $100 - GuruFocus
Disc Medicine's (IRON) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Form 8K Disc Medicine Inc For: 10 September By Investing.com - Investing.com Canada
Disc Medicine at Wells Fargo conference: two drug bets near key tests - Investing.com Canada
H.C. Wainwright reiterates Disc Medicine stock rating on trial data By Investing.com - Investing.com India
Disc Medicine reports Phase 2 DISC-3405 trial results - grafa.com
Disc Medicine stock rating held at Outperform by BMO on trial data - Investing.com Canada
Disc Medicine (IRON) Reports Promising Phase 2 Data; Market Pric - GuruFocus
Disc Medicine reports positive phase 2 trial results for DISC-3405 By Investing.com - Investing.com Australia
Disc Medicine Reports Positive Initial RESTORE-PV Results for DISC-3405 in Polycythemia Vera | IRON Stock News - Quiver Quantitative
Blood-removal procedures fell from 4.0 at baseline to 0.6 after treatment - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Insider Selling: Disc Medicine (NASDAQ:IRON) Director Sells $135,052.44 in Stock - MarketBeat
Disc Medicine (NASDAQ: IRON) director sells shares under preset plan - Stock Titan
Disc Medicine at cantorfitzgerald healthcare conference: pipeline nears key tests - Investing.com Canada
Disc Medicine faces class action over alleged m... - Pluang
Legal & General Group Plc Invests $1.35 Million in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Small Disc Medicine (NASDAQ: IRON) shareholder sale planned - Stock Titan
Disc Medicine (NASDAQ: IRON) files notice to sell about $60K in stock - Stock Titan
Disc Medicine (NASDAQ: IRON) holder plans $72K stock sale - Stock Titan
Proposed $176K Disc Medicine (NASDAQ: IRON) share sale by Atlas Venture Fund X - Stock Titan
Kevin Bitterman Sells 129 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Insider Selling: Disc Medicine (NASDAQ:IRON) Director Sells $3,941,477.88 in Stock - MarketBeat
Kevin Bitterman Sells 5,203 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (IRON) director's funds sell 54K shares in 10b5-1 trades - Stock Titan
Disc Medicine(IRON.US) Director Sells US$4.37 Million in Common Stock - Moomoo
Atlas fund plans small Disc Medicine (NASDAQ: IRON) share sale - Stock Titan
Venture fund plans Disc Medicine (IRON) share sale - Stock Titan
Disc Medicine (NASDAQ: IRON) investor plans $225K stock sale - Stock Titan
Disc Medicine (IRON) investor plans 2,339-share sale - Stock Titan
Man Group plc Takes $1.09 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
The Manufacturers Life Insurance Company Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Venture fund to sell 513 Disc Medicine (NASDAQ: IRON) shares - Stock Titan
Disc Medicine (NASDAQ: IRON) investor plans Rule 144 share sale - Stock Titan
Venture backer plans Disc Medicine (NASDAQ: IRON) share sale - Stock Titan
Venture fund plans Disc Medicine (IRON) share resale - Stock Titan
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
IRON Maintained by Wedbush -- Price Target Raised to $100 - GuruFocus
Disc Medicine (NASDAQ:IRON) Price Target Raised to $100.00 at Wedbush - MarketBeat
Disc Medicine to Participate in Upcoming Investor Conferences - The Manila Times
Four live webcasts are planned for September, with replays after each - Stock Titan
Bank of New York Mellon Corp Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Cantor Fitzgerald reiterates Disc Medicine stock rating on survey data By Investing.com - Investing.com Nigeria
Cantor Fitzgerald reiterates Disc Medicine stock rating on survey data - Investing.com
Disc Medicine faces class action after FDA reje... - Pluang
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - prnewswire.com
Disc Medicine Announces Multiple Presentations Across Portfolio at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting - The Manila Times
Disc Medicine to Present RESTORE-PV and RALLY-MF Data at SOHO Annual Meeting - Quiver Quantitative
Disc Medicine (NASDAQ:IRON) Cut to "Sell" at Wall Street Zen - MarketBeat
Disc Medicine (IRON) Faces Legal Scrutiny, Is The Stock Still Cheap? - Sahm
Deutsche Bank AG Acquires New Holdings in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (IRON): Betting On Iron And Heme Biology - RTTNews
Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Disc medicine COO Yu sells $755,851 in shares By Investing.com - Investing.com South Africa
Disc Medicine (NASDAQ:IRON) COO Jonathan Yen-Wen Yu Sells 8,796 Shares - MarketBeat
Disc Medicine (NASDAQ:IRON) COO Sells $24,759.00 in Stock - marketbeat.com
Disc Medicine (IRON) COO sells 9,096 shares at ~$83 - Stock Titan
Disc medicine COO Yu sells $755,851 in shares - Investing.com
Disc Medicine faces class action over FDA rejec... - Pluang
Will FDA Bitopertin Rejection and New Legal Probe Change Disc Medicine's (IRON) Narrative? - Sahm
Disc (IRON) Quarterly Figures: EPS Exceeds Its Estimate for the Current Session; Price Reaction: Shares Move 1.84% Lower in the Available RecordQuarterly Earnings - vinanet.vn
Rosen Law Firm investigates Disc Medicine over potential securities claims - scanx.trade
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):